Targeted Radiotherapy
About us
- Team
- Contact
- Directions
News
Careers
Search
Menu Menu

Blog - Latest News

You are here: Home1 / 20162 / KNAUER and 3B Pharmaceuticals showcase novel affinity purification process...

8. November 2016/by imken

KNAUER and 3B Pharmaceuticals showcase novel affinity purification process for camelid antibodies

Share this entry

Share on Facebook
Share on Twitter
Share on Pinterest
Share on LinkedIn
Share on Tumblr
Share on Vk
Share on Reddit
Share by Mail

https://3b-pharma.com/wp/wp-content/uploads/2019/07/logo-1.png 0 0 imken https://3b-pharma.com/wp/wp-content/uploads/2019/07/logo-1.png imken2016-11-08 14:44:312019-07-26 16:12:50KNAUER and 3B Pharmaceuticals showcase novel affinity purification process for camelid antibodies

Imprint
Data privacy statement

3B Pharmaceuticals GmbH
Magnusstraße 11
D-12489 Berlin
Tel: +49 (0)30 / 63 92 - 43 17
Fax: +49 (0)30 / 63 92 - 43 16
info@3b-pharma.com

Ipsen enters into a licensing agreement with 3B Pharmaceuticals to develop novel...3B Pharmaceuticals and Sovicell introduce a novel service offering for plasma...

Scroll to top